# Heidelberg Engineering

its Spectralis OCT platform, originally built for ophthalmology, is now widely used as a research and clinical tool for OCT-based structural and vascular biomarkers linked to neurodegenerative disease, documented across multiple 2026 publications including JAMA Ophthalmology.

Source: https://en.bioecon.ru/companies/heidelberg-engineering/
Updated: 2026-07-20

- Country: Germany

## Technologies

- [Retinal biomarkers for neurodegenerative disease](https://en.bioecon.ru/technology/retinal-biomarkers-neurodegenerative-disease/)